MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-BR-26-0033873
Kras Pharmaceuticals Private Limited
Kras Pharmaceuticals Private Limited - pharma in Fatuha, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.05 Cr
▲ 45% YoY
Net profit · FY 2025
₹25.14 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹81.67 Lakh
EBITDA margin 5.4%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹3.22 Cr
Secured borrowings
Company age
41 yrs
Est. 1985
Directors on board
3
As per MCA filings
About Kras Pharmaceuticals Private Limited
Data last updated:
Kras Pharmaceuticals Private Limited is a private limited company based in Fatuha, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 September 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U00304BR1985PTC002219. Its GSTIN is 10AABCK5827F1ZZ (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Ravi Shankar and Vinita Bhushan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Kras Pharmaceuticals Private Ltd C – 15 2nd Phase Industrial Area, Fatuha, Bihar, India – 803201.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.05 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹25.14 Lakh (net margin 1.7%) and EBITDA of ₹81.67 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 43% over five years.
As per MCA filings, the company has open charges of ₹3.22 Cr on record. Court records list 10 cases involving the company, including 6 filed by the company and 4 filed against it; 3 cases are pending.
Kras Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0033873). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U00304BR1985PTC002219
Registration Number 002219
Incorporation Date 27 September 1985
ROC Patna
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-BR-26-0033873
Recognitions & Rankings of Kras Pharmaceuticals
Contact details
Kras Pharmaceuticals Private Limited's registered office is in Fatuha, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Kras Pharmaceuticals Private Ltd C – 15 2nd Phase Industrial Area, Fatuha, Bihar, India – 803201
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kras Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kras Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kras Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kras Pharmaceuticals Private Limited, buy the company report.
Financials of Kras Pharmaceuticals Private Limited
FY 2025 filings availableKras Pharmaceuticals Private Limited reported revenue of ₹15.05 Cr (up 45% YoY) for FY 2025.
Revenue · FY 2025
₹15.05 Cr ▲ 45%
Net profit · FY 2025
₹25.14 Lakh margin 1.7%
EBITDA · FY 2025
₹81.67 Lakh margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 61%
5 years · compounded
▲ 43%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 77%
5 years · compounded
▲ 37%
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 45% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹81.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kras Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kras Pharmaceuticals Private Limited
Kras Pharmaceuticals has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Shankar Also directs: Venus Lifescience Private Limited. | Director | 02 Jan 2019 | 7 Years 10 Months | Current |
| Vinita Bhushan | Director | 01 Sep 2020 | 6 Years 2 Months | Current |
| Rupesh Kumar Also directs: Venus Lifescience Private Limited. | Director | 01 Sep 2020 | 6 Years 2 Months | Current |
Peer comparison
Kras Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arco Pharma Private Limited | ₹15.11 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Coax Bioremedies Private Limited | ₹15.08 Cr (FY 2025) | 33.0% | Haryana, India | |||
| Kras Pharmaceuticals Private Limitedthis company | ₹15.05 Cr (FY 2025) | ₹25.14 Lakh | 1.7% | 45.0% | Fatuha, Bihar, India | |
| Kansas Laboratories Pvt Ltd | ₹15.04 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Grindlays Pharmaceuticals Pvt Ltd | ₹14.96 Cr (FY 2025) | 69.0% | Mumbai, Maharashtra, India | |||
| Santexo Pharma Private Limited | ₹14.95 Cr (FY 2025) | 86.0% | New Delhi, Delhi, India | |||
| Revive Formulations India Private Limited | ₹14.93 Cr (FY 2024) | 5.0% | Vanur, Tamil Nadu, India | |||
| Theo Pharma Pvt Ltd | ₹14.91 Cr (FY 2025) | 26.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Kras Pharmaceuticals Private Limited, buy the company report.
Auditor
Kras Pharmaceuticals Private Limited is audited by R N SINGH & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R N SINGH & CO. | FY 2022 | 0322066E |
Shareholding
The shareholding of Kras Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kras Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.22 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2023 | 100922316 | Hdfc Bank Limited | ₹58.7 Lakh | Open | |
| 09 Sep 2022 | 100676472 | Hdfc Bank Limited | ₹2.4 Cr | Open | |
| 29 Dec 2021 | 100560160 | Indian Bank | ₹23.78 Lakh | Open |
To see the full charge records of Kras Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Kras Pharmaceuticals Private Limited has 10 court cases on record: 6 filed by Kras Pharmaceuticals, 4 filed against it. 3 cases are pending and 7 are disposed.
Total cases
10
Filed by the company
6
Filed against the company
4
Pending
3
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 0 | 0 |
| District courts | 4 | 4 | 3 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Court case (CS CCC) | Filed against the company by Indon Healthcare Ltd. | Disposed |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed against the company by an individual | Pending |
| District court, Hapur, Uttar Pradesh | Criminal case | Filed against the company by Union of India Through Drugs Inspector | Pending |
| District court, Deoghar, Jharkhand | Court case (Drugs and Cosmetic act) | Filed against the company by an individual | Pending |
| Allahabad High Court | Writ petition | Filed by the company against State of Up Thru Prin Secy Medical Health and Family Wel.Andanr | Disposed |
To see the full case history of Kras Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kras Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kras Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCK5827F1ZZ | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kras Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kras Pharmaceuticals Private Limited has 17 board changes on record since 2007: 3 appointments and 14 cessations. The latest: Atindra Bhooshan ceased to be Director on 01 Sep 2020.
AGM
Kras Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kras Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Charges
A charge with Hdfc Bank Limited of Rs. 2.40 Cr registered on 09 Sep 2022 with Charge ID 100676472 was modified on 08 Aug 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.59 Cr with Charge ID 100922316 was registered on 30 Dec 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.40 Cr with Charge ID 100676472 was registered on 09 Sep 2022.
Charges
A charge with Indian Bank amounted to Rs. 0.24 Cr with Charge ID 100560160 was registered on 29 Dec 2021.
Ceased
Atindra Bhooshan ceased to be Director.
Appointed
Rupesh Kumar was appointed as Director.
Appointed
Vinita Bhushan was appointed as Director.
Appointed
Ravi Shankar was appointed as Director.
Ceased
Rupesh Kumar ceased to be Director.
Ceased
Vinita Bhushan ceased to be Director.
12 earlier events are in the company report.
Frequently asked questions
Kras Pharmaceuticals is an active private limited company based in Fatuha, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 September 1985 (41+ years old) and is registered under CIN U00304BR1985PTC002219.
Kras Pharmaceuticals has 3 current directors:
- Ravi Shankar - Director
- Vinita Bhushan - Director
- Rupesh Kumar - Director
The latest financial statements of Kras Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kras Pharmaceuticals is 10AABCK5827F1ZZ, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Kras Pharmaceuticals is U00304BR1985PTC002219. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kras Pharmaceuticals has 10 court cases on record: 6 filed by the company and 4 filed against it. 3 are pending. Most are in the high courts.
Kras Pharmaceuticals was incorporated on 27 September 1985, making it 41+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Kras Pharmaceuticals by revenue are Arco Pharma Private Limited, Coax Bioremedies Private Limited, Kansas Laboratories Pvt Ltd, Grindlays Pharmaceuticals Pvt Ltd, Santexo Pharma Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Atindra Bhooshan ceased to be Director on 01 Sep 2020. Rupesh Kumar was appointed as Director on 01 Sep 2020. Vinita Bhushan was appointed as Director on 01 Sep 2020. Kras Pharmaceuticals has 17 board changes on record in total.
Yes, Kras Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-BR-26-0033873).
The registered office of Kras Pharmaceuticals is at CO Kras Pharmaceuticals Private Ltd C – 15 2nd Phase Industrial Area, Fatuha, Bihar, India – 803201.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages